{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:06:56Z","timestamp":1774562816763,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,3,3]],"date-time":"2004-03-03T00:00:00Z","timestamp":1078272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>To compare the relative risks of upper GI haemorrhage (UGIH) in users of Newer versus Older, non\u2010specific NSAIDs when adjusted for channelling bias by regression on individual covariates, a propensity score and both.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cohort study of patients prescribed NSAIDs between June 1987 and January 2000. Exposure to Newer and Older non\u2010specific NSAIDs was identified, and risk factors evaluated for each patient. Results of multiple covariate analyses and the propensity scoring technique to assess potential channelling bias in comparisons between Newer and Older non\u2010specific NSAIDs were compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study included 7.1 thousand patient years (tpy) exposure to meloxicam, 1.6\u2009tpy exposure to coxibs, and 628\u2009tpy exposure to Older non\u2010specific NSAIDs. Patients receiving Newer NSAIDs were older, more likely to have a history of GI symptoms, and at higher risk for GI complications. Adjusting for these risk factors reduced the relative risks of UGIH on meloxicam and coxibs versus Older non\u2010specific NSAIDs to 0.84 (95%CI 0.60, 1.17) and 0.36 (0.14, 0.97) respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Channelling towards high GI risk patients occurred in the prescribing of Newer NSAIDs. Propensity scores highlighted the markedly different risk profiles of users of Newer and Older non\u2010specific NSAID. Correcting for channelling bias, coxib exposure, but not meloxicam exposure, was associated with less UGIH than Older non\u2010specific NSAID exposure. In the present study, corrections made by regression on a propensity score and on individual covariates were similar. Copyright \u00a9 2004 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.946","type":"journal-article","created":{"date-parts":[[2004,3,25]],"date-time":"2004-03-25T16:58:47Z","timestamp":1080233927000},"page":"345-353","source":"Crossref","is-referenced-by-count":13,"title":["Application of a propensity score to adjust for channelling bias with NSAIDs"],"prefix":"10.1002","volume":"13","author":[{"given":"S. V.","family":"Morant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pettitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,3,3]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.19.2947"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00229.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1557(200003\/04)9:2<113::AID-PDS478>3.0.CO;2-2"},{"key":"e_1_2_1_5_2","first-page":"1876","article-title":"Upper gastrointestinal tolerability of celecoxib, a COX\u20102 specific inhibitor, compared to naproxen and placebo","volume":"27","author":"Bensen WG","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02194.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.20.1929"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.19.2998"},{"key":"e_1_2_1_10_2","first-page":"35","article-title":"Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis","volume":"20","author":"McKenna F","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.10.1247"},{"key":"e_1_2_1_12_2","first-page":"1","article-title":"The incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs and older non\u2010specific nonsteroidal anti\u2010inflammatory drugs","volume":"52","author":"McDonald TM","year":"2003","journal-title":"Gut"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00701.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6779.766"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/70.1.41"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780101105"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7119.1333"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg115"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.946","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T19:10:10Z","timestamp":1700161810000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,3]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1002\/pds.946"],"URL":"https:\/\/doi.org\/10.1002\/pds.946","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,3]]}}}